Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04821622
Recruitment Status : Recruiting
First Posted : March 29, 2021
Last Update Posted : May 19, 2022
Sponsor:
Collaborator:
Astellas Pharma Inc
Information provided by (Responsible Party):
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 11, 2024
Estimated Study Completion Date : April 10, 2027